| 1.4 |
6.9 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.0 |
1.0 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.9 |
4.4 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.8 |
4.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.8 |
3.9 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.8 |
3.1 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.7 |
2.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.7 |
2.2 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.7 |
2.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.7 |
2.1 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.7 |
0.7 |
GO:0043317 |
regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.7 |
2.0 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.6 |
1.9 |
GO:0007497 |
posterior midgut development(GO:0007497) |
| 0.6 |
2.5 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.6 |
1.8 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.6 |
1.8 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.6 |
1.7 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.6 |
2.3 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.6 |
2.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.5 |
2.2 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.5 |
2.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 |
2.6 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 |
2.0 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.5 |
2.0 |
GO:0097069 |
response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.5 |
2.0 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.5 |
4.9 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.5 |
1.5 |
GO:0071812 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.5 |
1.5 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.5 |
4.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.5 |
1.4 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.5 |
1.4 |
GO:0017143 |
insecticide metabolic process(GO:0017143) |
| 0.4 |
2.7 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.4 |
1.3 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.4 |
2.6 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.4 |
0.4 |
GO:0072132 |
mesenchyme morphogenesis(GO:0072132) |
| 0.4 |
1.2 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.4 |
0.8 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 |
1.2 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.4 |
0.4 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 0.4 |
1.6 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 |
3.9 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.4 |
0.4 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.4 |
1.5 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.4 |
0.4 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.4 |
1.1 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.4 |
1.1 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.4 |
2.3 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.4 |
1.8 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.4 |
1.1 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.4 |
1.8 |
GO:0014040 |
positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.4 |
0.7 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.4 |
1.8 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.4 |
0.4 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
1.1 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 |
1.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
0.4 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 |
1.0 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.3 |
1.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
0.7 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.3 |
0.7 |
GO:0015802 |
basic amino acid transport(GO:0015802) arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 0.3 |
0.7 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.3 |
1.4 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.3 |
1.4 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.3 |
1.0 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.3 |
2.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
1.7 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.3 |
1.3 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.3 |
1.0 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.3 |
1.0 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 |
1.3 |
GO:0052214 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.3 |
1.3 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 |
0.7 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.3 |
3.9 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.3 |
1.0 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.3 |
1.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.3 |
1.3 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 |
2.6 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
1.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
3.8 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 |
1.9 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.3 |
0.6 |
GO:0034136 |
negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
| 0.3 |
0.9 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.3 |
1.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
0.9 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.3 |
2.5 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
0.6 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.3 |
1.8 |
GO:0048369 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.3 |
0.6 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.3 |
1.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
0.9 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
2.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 |
0.9 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.3 |
1.5 |
GO:1902728 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.3 |
2.7 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
1.2 |
GO:0009183 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.3 |
0.6 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
| 0.3 |
1.2 |
GO:0044053 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.3 |
0.3 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.3 |
0.9 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.3 |
0.9 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 |
0.9 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 |
0.9 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.3 |
1.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
0.8 |
GO:0043311 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.3 |
1.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
1.1 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 |
1.1 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 |
1.1 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.3 |
1.4 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 |
0.8 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.3 |
1.1 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.3 |
0.6 |
GO:0090291 |
negative regulation of osteoclast proliferation(GO:0090291) |
| 0.3 |
1.1 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 0.3 |
2.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.3 |
1.4 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.3 |
0.3 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.3 |
0.5 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.3 |
0.8 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.3 |
0.3 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
0.8 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
4.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
1.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.3 |
1.0 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
0.8 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.3 |
2.6 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
0.8 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.3 |
0.5 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 |
1.6 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.3 |
0.8 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 |
1.0 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 |
2.0 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
1.5 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.2 |
1.5 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 |
1.5 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 |
0.2 |
GO:0055123 |
digestive system development(GO:0055123) |
| 0.2 |
1.0 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
1.5 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.2 |
1.2 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
4.9 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 |
1.0 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.2 |
1.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
5.0 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
1.7 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
0.5 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 |
0.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
1.9 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.7 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.2 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.9 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.2 |
1.6 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.2 |
1.9 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
0.7 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.2 |
0.9 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 |
0.9 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
1.4 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.2 |
2.5 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.7 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
0.7 |
GO:1904404 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.2 |
2.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
1.6 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.2 |
1.1 |
GO:1901545 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.2 |
1.4 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
0.7 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 |
0.9 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
0.2 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.2 |
0.2 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.2 |
0.7 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.2 |
0.9 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.9 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 |
0.2 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.2 |
0.9 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.2 |
0.7 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 |
2.0 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 |
0.4 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.2 |
2.8 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.2 |
2.2 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
0.4 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.2 |
0.2 |
GO:0072599 |
establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.2 |
1.1 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.2 |
0.8 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.2 |
0.8 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
2.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.8 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
2.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
1.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
0.4 |
GO:0032965 |
regulation of collagen biosynthetic process(GO:0032965) |
| 0.2 |
0.6 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 |
0.6 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.2 |
0.6 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.2 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.2 |
GO:0043967 |
histone H4 acetylation(GO:0043967) |
| 0.2 |
1.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
1.6 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.2 |
1.4 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.6 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.2 |
0.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
1.0 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.2 |
0.4 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.2 |
0.8 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.2 |
0.6 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.2 |
0.4 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
0.2 |
GO:2001020 |
regulation of response to DNA damage stimulus(GO:2001020) |
| 0.2 |
0.4 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 |
2.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
3.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
0.8 |
GO:2000230 |
negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.2 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
0.2 |
GO:0071359 |
cellular response to dsRNA(GO:0071359) |
| 0.2 |
1.4 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.2 |
0.6 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.2 |
0.2 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 |
1.0 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
0.6 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
1.7 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.2 |
1.0 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 0.2 |
0.8 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
1.2 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
1.0 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.2 |
0.4 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.2 |
0.4 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.2 |
2.9 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
0.9 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.2 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
0.6 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.2 |
0.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
2.4 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
1.7 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.9 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 |
0.6 |
GO:1903515 |
calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.2 |
0.2 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.2 |
0.7 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.2 |
0.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.2 |
1.5 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 0.2 |
0.9 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 |
0.2 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.2 |
0.2 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.2 |
1.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
1.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
2.0 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.5 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.2 |
0.7 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
0.5 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.2 |
0.4 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.2 |
0.2 |
GO:0006771 |
riboflavin metabolic process(GO:0006771) |
| 0.2 |
0.5 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
0.9 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.2 |
1.4 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.5 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 |
2.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.2 |
1.2 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.2 |
0.4 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
1.9 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
0.5 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
0.9 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 |
3.7 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
0.4 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 |
0.7 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 |
0.9 |
GO:1904744 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.2 |
0.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.2 |
1.7 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.2 |
0.5 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 |
4.8 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
1.2 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.2 |
0.5 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 |
0.5 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 0.2 |
1.0 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
0.5 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 |
1.2 |
GO:2000782 |
unidimensional cell growth(GO:0009826) regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 |
0.9 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.2 |
0.5 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
1.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
1.0 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 |
3.0 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.2 |
0.5 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.2 |
0.5 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.2 |
1.2 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.2 |
0.7 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.2 |
0.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 |
0.5 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.8 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
3.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.5 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
1.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
0.5 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 |
2.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
0.5 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.2 |
0.8 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.2 |
0.6 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 |
3.2 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
1.0 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
1.0 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
1.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
0.3 |
GO:0098877 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) |
| 0.2 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
0.6 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 |
0.5 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 |
0.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.3 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 |
0.8 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 |
0.8 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 |
2.2 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.2 |
0.9 |
GO:0060324 |
face development(GO:0060324) |
| 0.2 |
2.2 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
0.3 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 0.2 |
0.8 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.2 |
1.2 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.2 |
0.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
0.5 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.2 |
0.3 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.2 |
0.5 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.2 |
0.8 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 |
1.8 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
| 0.2 |
0.2 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 |
0.8 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 |
0.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
1.7 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
0.8 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
1.2 |
GO:1902564 |
negative regulation of neutrophil activation(GO:1902564) |
| 0.2 |
0.5 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.5 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.2 |
1.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 |
0.9 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.3 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.1 |
0.7 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 |
1.2 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.6 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
0.9 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.2 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
0.3 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) negative regulation of hair follicle development(GO:0051799) |
| 0.1 |
0.7 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
1.5 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
2.9 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.6 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
1.4 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
3.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.1 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.9 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 |
0.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
0.6 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.1 |
1.0 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.3 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.1 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.8 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
3.7 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.4 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
0.6 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.7 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.1 |
0.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
1.0 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.6 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.8 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.3 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
1.4 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.6 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.1 |
0.4 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
1.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.8 |
GO:0035933 |
glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.1 |
0.4 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
1.1 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
1.5 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.1 |
0.7 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
1.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
9.2 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.7 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.1 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.1 |
0.9 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.1 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.1 |
0.4 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.1 |
0.8 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.3 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.1 |
1.1 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
1.9 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
2.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
1.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.1 |
GO:0045416 |
positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 |
3.2 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.1 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 |
1.6 |
GO:1904869 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 |
1.2 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.1 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.4 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
1.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
1.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.4 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
3.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.8 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.5 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 |
0.1 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.3 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
1.3 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.6 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.6 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
3.3 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
0.3 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
1.0 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 |
0.4 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 |
1.0 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
2.0 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.3 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.6 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.4 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.1 |
0.6 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.5 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
0.4 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
0.1 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.1 |
0.7 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.2 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.1 |
0.2 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.4 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 |
0.1 |
GO:1901018 |
positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
| 0.1 |
0.1 |
GO:0072028 |
nephron morphogenesis(GO:0072028) |
| 0.1 |
1.4 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.9 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 |
0.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.2 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.1 |
1.7 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.2 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.2 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.1 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.1 |
0.1 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.1 |
0.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.9 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.9 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
0.4 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
1.2 |
GO:1902915 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
1.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.4 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 |
0.7 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
0.1 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.1 |
2.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.8 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.8 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
1.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.6 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.5 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.8 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.2 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.1 |
0.2 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
1.3 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
1.0 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.7 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.4 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.6 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
0.1 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.1 |
0.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
3.8 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.1 |
1.0 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
1.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
1.4 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.7 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.1 |
0.7 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.9 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.2 |
GO:1904938 |
dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.1 |
0.3 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.1 |
0.1 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.3 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
1.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.2 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.7 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
1.8 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
1.3 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 |
0.6 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.1 |
0.4 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.3 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.5 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.4 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.2 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 |
0.1 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
1.8 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
1.5 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.3 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
1.4 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.2 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 |
0.5 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.1 |
0.4 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.6 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.1 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.2 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.1 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 |
1.0 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 |
1.0 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
1.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.3 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 |
0.3 |
GO:0035623 |
regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.1 |
1.0 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
3.8 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
1.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.3 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.1 |
0.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
0.4 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.7 |
GO:0031346 |
positive regulation of cell projection organization(GO:0031346) |
| 0.1 |
0.5 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
1.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.1 |
0.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
2.2 |
GO:1903203 |
regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.1 |
1.9 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.6 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
0.2 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
0.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
2.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.3 |
GO:1902741 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 |
0.7 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
0.7 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.2 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.3 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 |
0.2 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
0.2 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.7 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
1.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.4 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.9 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.5 |
GO:1903299 |
regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 0.1 |
1.6 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
0.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.1 |
0.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.6 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
1.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.6 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.4 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 |
0.3 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
1.0 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.7 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.4 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.1 |
0.5 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.2 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
| 0.1 |
0.3 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 |
0.2 |
GO:1901164 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
0.2 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 |
1.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.4 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.7 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.6 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.6 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.4 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.1 |
1.0 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.3 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.1 |
0.4 |
GO:0090647 |
modulation of age-related behavioral decline(GO:0090647) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.1 |
GO:0030324 |
lung development(GO:0030324) respiratory system development(GO:0060541) |
| 0.1 |
0.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.5 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
1.3 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.1 |
0.4 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.3 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.3 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.4 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.1 |
GO:0032205 |
negative regulation of telomere maintenance(GO:0032205) |
| 0.1 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.4 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.3 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.1 |
0.6 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
0.3 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.6 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
0.8 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 |
0.3 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
0.2 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
1.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.9 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.3 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.3 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
1.2 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
3.3 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
0.3 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.3 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
0.3 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.1 |
1.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.3 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 |
0.8 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.8 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
0.3 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.1 |
0.3 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.8 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.3 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.7 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.4 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 |
0.2 |
GO:2000617 |
positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.1 |
0.2 |
GO:0061053 |
somite development(GO:0061053) |
| 0.1 |
0.1 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.1 |
0.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.9 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 |
0.2 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.1 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.2 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.8 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 |
0.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 |
0.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.6 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.7 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 |
0.3 |
GO:0060413 |
atrial septum morphogenesis(GO:0060413) |
| 0.1 |
0.3 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.1 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.2 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.4 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.1 |
1.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
0.4 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.1 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
0.2 |
GO:0072175 |
embryonic epithelial tube formation(GO:0001838) epithelial tube formation(GO:0072175) |
| 0.1 |
0.3 |
GO:0060849 |
radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.1 |
0.1 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.2 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
0.2 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.4 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.8 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.2 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.1 |
0.2 |
GO:0034971 |
histone H3-R2 methylation(GO:0034970) histone H3-R17 methylation(GO:0034971) |
| 0.1 |
0.2 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.1 |
0.3 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
5.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.6 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 |
0.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.1 |
3.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.8 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
1.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.8 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.9 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.8 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.1 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 |
1.5 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.1 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.1 |
1.2 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.3 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 |
0.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
1.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.3 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.1 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
0.1 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
1.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.2 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
0.8 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 |
0.7 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
1.7 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 |
0.2 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 |
1.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.2 |
GO:0021799 |
cerebral cortex radially oriented cell migration(GO:0021799) |
| 0.1 |
0.3 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
1.0 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.1 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
0.9 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.7 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
1.0 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.4 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.1 |
0.5 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.6 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 |
0.2 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
0.8 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.7 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.1 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 |
0.1 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.1 |
0.1 |
GO:0001906 |
cell killing(GO:0001906) |
| 0.1 |
0.1 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.1 |
3.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.2 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.1 |
0.1 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 |
1.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
1.3 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.2 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
1.1 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
0.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 |
0.7 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.3 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 |
0.2 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.8 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.1 |
0.8 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.1 |
GO:0032845 |
negative regulation of homeostatic process(GO:0032845) |
| 0.1 |
0.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.1 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.1 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 |
0.4 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.1 |
0.3 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 |
0.3 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.1 |
0.2 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
1.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.9 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
0.7 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 |
0.5 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.2 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.1 |
0.5 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.6 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.6 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.7 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 |
0.5 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.1 |
0.5 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.1 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.6 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.1 |
0.4 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.1 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
1.9 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 |
0.2 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
1.1 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 |
0.2 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.5 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
1.4 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
0.1 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.4 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
1.2 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.6 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.3 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.5 |
GO:0048385 |
regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.1 |
0.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.9 |
GO:0019054 |
modulation by virus of host process(GO:0019054) |
| 0.1 |
0.3 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
1.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.2 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.1 |
0.9 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.3 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
0.1 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.2 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.1 |
2.8 |
GO:1990090 |
cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
0.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.1 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.1 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.1 |
1.0 |
GO:0051769 |
nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
| 0.1 |
0.5 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.2 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.2 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.9 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
0.9 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.1 |
0.7 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 |
0.5 |
GO:0060486 |
Clara cell differentiation(GO:0060486) |
| 0.1 |
3.6 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
0.5 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
0.1 |
GO:0000423 |
macromitophagy(GO:0000423) |
| 0.1 |
0.4 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 |
0.2 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 |
0.6 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
1.2 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.7 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
0.2 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
1.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.4 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
2.6 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 |
0.4 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.2 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.1 |
1.0 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 0.1 |
0.9 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
1.7 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.3 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.6 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.4 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.9 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.3 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.3 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.3 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
0.4 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.1 |
0.8 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.1 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 |
0.6 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.1 |
0.1 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.1 |
0.1 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
| 0.1 |
0.1 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.1 |
1.7 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
0.2 |
GO:1904356 |
regulation of telomere maintenance via telomere lengthening(GO:1904356) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.4 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
0.1 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.8 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
0.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.1 |
GO:0045713 |
low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 |
0.5 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.3 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 |
0.2 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 |
0.5 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.5 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.1 |
0.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
0.4 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
1.1 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.1 |
1.0 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.6 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 |
0.3 |
GO:0032239 |
regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.1 |
0.1 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.1 |
0.1 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
0.2 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
1.1 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.2 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.1 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
1.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
3.6 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.3 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
1.0 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.1 |
0.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.2 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
1.3 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.6 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
5.8 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.3 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.1 |
1.8 |
GO:0043631 |
mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.1 |
1.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
1.1 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.9 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.2 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.0 |
0.2 |
GO:0060142 |
regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
| 0.0 |
0.3 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.6 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.1 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
1.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
0.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.1 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.2 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.0 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 |
1.1 |
GO:0006937 |
regulation of muscle contraction(GO:0006937) |
| 0.0 |
0.1 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.0 |
0.1 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.0 |
0.4 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 |
0.0 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
2.1 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.1 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.3 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
0.3 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.0 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.4 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.2 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.0 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.5 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.0 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 |
0.2 |
GO:0030805 |
regulation of cyclic nucleotide catabolic process(GO:0030805) positive regulation of cyclic nucleotide catabolic process(GO:0030807) regulation of cAMP catabolic process(GO:0030820) positive regulation of cAMP catabolic process(GO:0030822) regulation of purine nucleotide catabolic process(GO:0033121) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.0 |
0.5 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
1.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.0 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
4.3 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.0 |
0.5 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.1 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
1.0 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.9 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.2 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.0 |
0.4 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.3 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.3 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 |
0.0 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.0 |
0.1 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 |
0.1 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.0 |
0.1 |
GO:0002687 |
positive regulation of leukocyte migration(GO:0002687) |
| 0.0 |
0.2 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.0 |
0.1 |
GO:0032431 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
1.1 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
3.1 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.1 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.0 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.3 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.1 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.0 |
0.1 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.0 |
0.0 |
GO:0031620 |
regulation of fever generation(GO:0031620) |
| 0.0 |
0.4 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.1 |
GO:0009180 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 |
0.1 |
GO:0048738 |
cardiac muscle tissue development(GO:0048738) |
| 0.0 |
0.0 |
GO:0043584 |
nose development(GO:0043584) |
| 0.0 |
0.0 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
0.1 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.3 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.3 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
1.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.1 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.0 |
0.0 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 |
1.5 |
GO:0010762 |
regulation of fibroblast migration(GO:0010762) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.0 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.1 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.2 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.6 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.0 |
0.1 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 |
0.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
1.3 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.2 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.1 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.2 |
GO:2000697 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.0 |
0.3 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.5 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.0 |
0.1 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 |
0.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.0 |
GO:0043324 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.1 |
GO:0043300 |
regulation of leukocyte degranulation(GO:0043300) |
| 0.0 |
1.2 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.0 |
GO:0052490 |
negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 |
0.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
4.1 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.2 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
1.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.7 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.4 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.1 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) |
| 0.0 |
0.1 |
GO:0072666 |
establishment of protein localization to vacuole(GO:0072666) |
| 0.0 |
0.2 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.0 |
0.0 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.0 |
0.4 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.6 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.0 |
0.1 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.2 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.0 |
0.6 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.0 |
1.0 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.2 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.0 |
0.0 |
GO:0031587 |
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.0 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 |
0.3 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.3 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.0 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.0 |
0.0 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.0 |
0.1 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.2 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.0 |
GO:0003266 |
regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.0 |
0.0 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.0 |
0.7 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.0 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.0 |
0.4 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.3 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.0 |
0.1 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.0 |
0.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
1.5 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.5 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.0 |
0.1 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
1.3 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
0.4 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 |
0.0 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.1 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) |
| 0.0 |
0.2 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:1900745 |
regulation of p38MAPK cascade(GO:1900744) positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.2 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.2 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 |
0.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.2 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.3 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.3 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
2.0 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.0 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.2 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.0 |
0.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.0 |
0.0 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.2 |
GO:0018023 |
peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 |
0.1 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.0 |
0.3 |
GO:2000482 |
regulation of interleukin-8 secretion(GO:2000482) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.1 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
0.6 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.1 |
GO:0060558 |
regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
| 0.0 |
0.0 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.0 |
0.8 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.7 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 |
0.0 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.0 |
1.1 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 |
0.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.6 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.0 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.0 |
0.0 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.0 |
0.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.0 |
0.0 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.0 |
1.7 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
1.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.7 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.0 |
1.6 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.4 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.0 |
0.0 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.0 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.0 |
0.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.1 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.0 |
0.1 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.2 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.0 |
0.5 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 |
0.3 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.1 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 |
0.2 |
GO:2000848 |
positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.0 |
0.1 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.0 |
0.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.3 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.0 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.0 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 |
1.1 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.0 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.0 |
0.1 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.0 |
0.2 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.3 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.0 |
0.3 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 |
0.0 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.0 |
0.1 |
GO:0022898 |
regulation of transmembrane transporter activity(GO:0022898) |
| 0.0 |
0.0 |
GO:0001823 |
mesonephros development(GO:0001823) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.3 |
GO:0030183 |
B cell differentiation(GO:0030183) |
| 0.0 |
0.3 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.1 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.4 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.0 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.2 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.0 |
0.3 |
GO:1903670 |
regulation of sprouting angiogenesis(GO:1903670) |
| 0.0 |
0.6 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.1 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.1 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.0 |
0.1 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.1 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.2 |
GO:0034465 |
response to carbon monoxide(GO:0034465) smooth muscle contraction involved in micturition(GO:0060083) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.7 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.3 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.2 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.0 |
0.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
1.4 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.2 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.6 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.2 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
1.4 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.2 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.0 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.5 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.0 |
0.2 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
1.2 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
0.1 |
GO:1902170 |
cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
| 0.0 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.0 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.1 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.6 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.4 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.1 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.0 |
0.1 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.0 |
0.0 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 |
0.3 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.0 |
0.0 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.0 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.2 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
1.0 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:1900040 |
regulation of interleukin-2 secretion(GO:1900040) |
| 0.0 |
0.1 |
GO:0051177 |
meiotic sister chromatid cohesion(GO:0051177) |
| 0.0 |
0.0 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.0 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.0 |
0.0 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.2 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.0 |
0.3 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.0 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.0 |
0.6 |
GO:0021543 |
pallium development(GO:0021543) |
| 0.0 |
0.1 |
GO:0097050 |
type B pancreatic cell apoptotic process(GO:0097050) |
| 0.0 |
0.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.1 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.1 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.0 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.0 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.3 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 |
1.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.1 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.5 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.0 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.2 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.0 |
0.5 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.2 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.1 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 0.0 |
0.0 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.0 |
0.0 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.0 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.0 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.3 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.0 |
0.5 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
0.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.0 |
0.1 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.0 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.0 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.2 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.0 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.0 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.1 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.0 |
0.1 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.0 |
GO:0043038 |
amino acid activation(GO:0043038) |
| 0.0 |
0.1 |
GO:0098597 |
observational learning(GO:0098597) |
| 0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.7 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.0 |
GO:0072235 |
metanephric distal tubule development(GO:0072235) |
| 0.0 |
0.0 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 |
0.0 |
GO:0072606 |
interleukin-8 secretion(GO:0072606) |
| 0.0 |
0.1 |
GO:0098732 |
macromolecule deacylation(GO:0098732) |
| 0.0 |
0.5 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.2 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.1 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.0 |
0.1 |
GO:0001207 |
histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.0 |
0.1 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.0 |
0.0 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.0 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.0 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
0.4 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.0 |
0.3 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.0 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.0 |
GO:0008306 |
associative learning(GO:0008306) |
| 0.0 |
0.1 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.2 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.0 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.2 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.1 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.1 |
GO:0006311 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.0 |
0.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.0 |
0.1 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.2 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.1 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.0 |
0.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:1901215 |
negative regulation of neuron death(GO:1901215) |
| 0.0 |
0.1 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.0 |
GO:0045577 |
regulation of B cell differentiation(GO:0045577) |
| 0.0 |
0.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.0 |
0.1 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 |
0.1 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.0 |
0.0 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.8 |
GO:0051351 |
positive regulation of ligase activity(GO:0051351) |
| 0.0 |
5.7 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.0 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.0 |
0.1 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 |
0.1 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.2 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.1 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.0 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.1 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.0 |
0.1 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.0 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.0 |
0.3 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 |
1.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
1.9 |
GO:0008037 |
cell recognition(GO:0008037) |
| 0.0 |
0.1 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.0 |
0.0 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.0 |
0.1 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.4 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.0 |
GO:0021626 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.0 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.0 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.0 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
0.0 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.1 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.0 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.0 |
GO:1904589 |
regulation of protein import(GO:1904589) |
| 0.0 |
0.1 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.1 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.1 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.0 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.0 |
GO:0061724 |
lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.0 |
GO:0070988 |
demethylation(GO:0070988) |
| 0.0 |
0.2 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.0 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.2 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.2 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.0 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.3 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.0 |
0.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.0 |
0.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0002369 |
T cell cytokine production(GO:0002369) |
| 0.0 |
0.0 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.0 |
0.0 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.0 |
0.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.0 |
0.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.1 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.0 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.0 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.0 |
0.2 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 |
0.0 |
GO:0044117 |
growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.0 |
0.0 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.0 |
0.0 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.0 |
0.0 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.0 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.0 |
0.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.0 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.0 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.0 |
0.1 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.0 |
0.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.0 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.2 |
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.0 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.0 |
0.3 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.0 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.0 |
0.0 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.0 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:1900084 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.0 |
0.4 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.0 |
GO:0072160 |
nephron tubule epithelial cell differentiation(GO:0072160) |
